Filing Details
- Accession Number:
- 0000939767-25-000022
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-19 20:31:26
- Reporting Period:
- 2025-02-14
- Filing Date:
- 2025-02-19
- Accepted Time:
- 2025-02-19 20:31:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 939767 | Exelixis Inc. | EXEL | Biological Products, (No Disgnostic Substances) (2836) | 043257395 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1547999 | C Maria Freire | C/O Exelixis, Inc. 1851 Harbor Bay Parkway Alameda CA 94502 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-02-14 | 15,874 | $20.50 | 106,881 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2025-02-14 | 28,240 | $22.10 | 135,121 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-02-14 | 44,114 | $34.94 | 91,007 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option (right to buy) | Disposition | 2025-02-14 | 15,874 | $0.00 | 15,874 | $20.50 |
| Common Stock | Option (right to buy) | Disposition | 2025-02-14 | 28,240 | $0.00 | 28,240 | $22.10 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2018-05-24 | 2025-05-23 | No | 4 | M | Direct |
| 0 | 2018-04-05 | 2025-04-04 | No | 4 | M | Direct |
Footnotes
- Includes 18,838 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economicequivalent of one share of Common Stock.
- Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $34.92 to $35.02. Reporting Person undertakes to provide Exelixis, Inc., any securityholder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth infootnote 2 to this Form 4.
- The option, representing the right to purchase a total of 15,874 shares of Common Stock, became fully exercisable on May 24, 2018.
- The option, representing the right to purchase a total of 28,240 shares of Common Stock, became fully exercisable on April 5, 2018.
Billionaire Hedge Funds
